Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Biomarker exploration and its clinical use].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan - 1 Jan 2013

Saito Yoshiro, Sai Kimie, Kaniwa Nahoko, Tajima Yoko, Ishikawa Masaki, Nishimaki-Mogami Tomoko, Maekawa Keiko

Abstract excerpt

Biomarkers are useful tools as indicators/predictors of disease severity and drug responsiveness, and thus, are expected to make drug development more efficient and to accelerate proper use of approved drugs. Many academic achievements on biomarkers have been reported, but only several biomarkers are used in drug development and clinical settings. We first show our results on the pharmacogenomic analysis of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Biomarkers
Share to Genome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipid Metabolism

Share to Metabolomics

Source

Identifiers

PMID: 24292186
DOI: 10.1248/yakushi.13-00232-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Biomarker exploration and its clinical use].PMID 24292186Read ↗

[Predictive genomic markers for severe adverse drug reactions].Semantic proximity Read ↗

[Pharmacogenomics: current status and future prospectives].Semantic proximity Read ↗

[Genetic susceptibility to drug-induced liver injury].Semantic proximity Read ↗

[Significance of TDM, phenotyping and genotyping for the correct drug dosage].Semantic proximity Read ↗

Research Progress of Pharmacogenomics in Drug-Induced Liver InjurySemantic proximity Read ↗

Biostatistic tools in pharmacogenomics--advances, challenges, potential.Semantic proximity Read ↗

[The present status and future prospect of the molecular diagnostic tests].Semantic proximity Read ↗

[To promise personalized medicine: development of world's fastest SNP detection method to circumvent drug-induced adverse reactions].Semantic proximity Read ↗

[Correlation between single nucleotide polymorphisms and hematological malignancies].Semantic proximity Read ↗

[Clinical toxicology and metabonomics].Semantic proximity Read ↗

Causal effects of plasma metabolites on autoimmune hepatitis (AIH): a bidirectional two-sample mendelian randomization study.Semantic proximity Read ↗

Biomarkers in Disease Diagnosis and Monitoring: Insights into Clinical Applications and Mass Spectrometry-based DetectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.